Split History
ETFs Holding BMY »    BMY Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co. has products in the following therapeutic classes, among others: virology, including human immunodeficiency virus infection; oncology; neuroscience; immunoscience; and cardiovascular. Co.'s products include: Abilify, an atypical antipsychotic agent for adult patients with schizophrenia, bipolar mania disorder and depressive disorder; and Baraclude (entecavir) is a selective inhibitor of hepatitis B virus that was approved by the U.S. Food and Drug Administration for the treatment of chronic hepatitis B virus infection. According to our BMY split history records, Bristol-Myers Squibb has had 6 splits.
BMY split history picture
Bristol-Myers Squibb (BMY) has 6 splits in our BMY split history database. The first split for BMY took place on May 31, 1977. This was a 2 for 1 split, meaning for each share of BMY owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. BMY's second split took place on May 27, 1983. This was a 2 for 1 split, meaning for each share of BMY owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split. BMY's third split took place on June 10, 1987. This was a 2 for 1 split, meaning for each share of BMY owned pre-split, the shareholder now owned 2 shares. For example, a 4000 share position pre-split, became a 8000 share position following the split. BMY's 4th split took place on March 03, 1997. This was a 2 for 1 split, meaning for each share of BMY owned pre-split, the shareholder now owned 2 shares. For example, a 8000 share position pre-split, became a 16000 share position following the split. BMY's 5th split took place on March 01, 1999. This was a 2 for 1 split, meaning for each share of BMY owned pre-split, the shareholder now owned 2 shares. For example, a 16000 share position pre-split, became a 32000 share position following the split. BMY's 6th split took place on August 07, 2001. This was a 1000000 for 951777 split, meaning for each 951777 shares of BMY owned pre-split, the shareholder now owned 1000000 shares. For example, a 32000 share position pre-split, became a 33621.3209606872 share position following the split.

When a company such as Bristol-Myers Squibb splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the BMY split history from start to finish, an original position size of 1000 shares would have turned into 33621.3209606872 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bristol-Myers Squibb shares, starting with a $10,000 purchase of BMY, presented on a split-history-adjusted basis factoring in the complete BMY split history. BMY split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 04/24/2007
End date: 04/21/2017
Start price/share: $28.78
End price/share: $53.48
Starting shares: 347.46
Ending shares: 512.67
Dividends reinvested/share: $13.62
Total return: 174.18%
Average Annual Total Return: 10.61%
Starting investment: $10,000.00
Ending investment: $27,412.20
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/24/2007
End date: 04/21/2017
Start price/share: $28.78
End price/share: $53.48
Dividends collected/share: $13.62
Total return: 133.15%
Average Annual Total Return: 8.83%
Starting investment: $10,000.00
Ending investment: $23,307.00
Years: 10.00
Date Ratio
05/31/19772 for 1
05/27/19832 for 1
06/10/19872 for 1
03/03/19972 for 1
03/01/19992 for 1
08/07/20011000000 for 951777
BMY is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

BOC Split History
BONE Split History
BOTA Split History
BRLI Split History
BSPM Split History
BSTC Split History
BSX Split History
BTX Split History
CAH Split History
CALA Split History

Rexahn Pharmaceuticals, Inc. (RNN)
Immune Pharmaceuticals Inc. (INMP)
DryShips Inc. (DRYS)
STRATA Skin Sciences, Inc. (SSKN)
Quantum Corp. (QTM)
German American Bancorp, Inc. (GABC)
Pacific Energy Development (PED)
The GEO Group, Inc. (GEO)
Copart, Inc. (CPRT)
HEICO Corporation (HEI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BMY Insider Buying

BMY Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.